PT3102565T - Processos para a preparação de intermediários de raltegravir - Google Patents
Processos para a preparação de intermediários de raltegravirInfo
- Publication number
- PT3102565T PT3102565T PT15708328T PT15708328T PT3102565T PT 3102565 T PT3102565 T PT 3102565T PT 15708328 T PT15708328 T PT 15708328T PT 15708328 T PT15708328 T PT 15708328T PT 3102565 T PT3102565 T PT 3102565T
- Authority
- PT
- Portugal
- Prior art keywords
- raltegravir
- intermediates
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN471CH2014 | 2014-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3102565T true PT3102565T (pt) | 2019-04-01 |
Family
ID=52629638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT15708328T PT3102565T (pt) | 2014-02-03 | 2015-02-03 | Processos para a preparação de intermediários de raltegravir |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20170253585A1 (pt) |
| EP (1) | EP3102565B1 (pt) |
| CA (1) | CA2938387C (pt) |
| ES (1) | ES2713686T3 (pt) |
| PT (1) | PT3102565T (pt) |
| WO (1) | WO2015114608A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3119773A1 (en) | 2014-03-21 | 2017-01-25 | Mylan Laboratories Ltd. | A premix of crystalline raltegravir potassium salt and a process for the preparation thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0855397B1 (en) * | 1995-07-28 | 2001-05-09 | Dainippon Pharmaceutical Co., Ltd. | (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same |
| CN102219750B (zh) | 2001-10-26 | 2013-05-29 | P.安杰莱蒂分子生物学研究所 | 关于hiv整合酶的n-取代的羟基嘧啶酮甲酰胺抑制剂 |
| UA87884C2 (uk) | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| CA2710987A1 (en) | 2008-01-08 | 2009-07-16 | Merck Sharp & Dohme Corp. | Process for preparing n-substituted hydroxypyrimidinone carboxamides |
| EP2438062B1 (en) | 2009-06-02 | 2015-07-29 | Hetero Research Foundation | Process for the preparation of amorphous raltegravir potassium |
| WO2011024192A2 (en) | 2009-07-27 | 2011-03-03 | Matrix Laboratories Ltd | Novel polymorphs of raltegravir |
| WO2012103105A1 (en) * | 2011-01-24 | 2012-08-02 | Assia Chemical Industries Ltd. | Processes for preparing raltegravir and intermediates in the processes |
| ES2825029T3 (es) * | 2011-12-26 | 2021-05-14 | Emcure Pharmaceuticals Ltd | Síntesis de raltegravir |
| EP3119773A1 (en) * | 2014-03-21 | 2017-01-25 | Mylan Laboratories Ltd. | A premix of crystalline raltegravir potassium salt and a process for the preparation thereof |
| WO2016075605A1 (en) * | 2014-11-10 | 2016-05-19 | Aurobindo Pharma Ltd | An improved process for the preparation of raltegravir |
-
2015
- 2015-02-03 CA CA2938387A patent/CA2938387C/en not_active Expired - Fee Related
- 2015-02-03 WO PCT/IB2015/050808 patent/WO2015114608A1/en active Application Filing
- 2015-02-03 EP EP15708328.8A patent/EP3102565B1/en active Active
- 2015-02-03 ES ES15708328T patent/ES2713686T3/es active Active
- 2015-02-03 PT PT15708328T patent/PT3102565T/pt unknown
- 2015-02-03 US US15/116,100 patent/US20170253585A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170253585A1 (en) | 2017-09-07 |
| EP3102565A1 (en) | 2016-12-14 |
| CA2938387C (en) | 2021-03-02 |
| ES2713686T3 (es) | 2019-05-23 |
| CA2938387A1 (en) | 2015-08-06 |
| WO2015114608A1 (en) | 2015-08-06 |
| EP3102565B1 (en) | 2019-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL251560A0 (en) | Methods for preparing ribosides | |
| ZA201706795B (en) | Process for the preparation of dicycloplatin | |
| IL250441B (en) | A method for the production of 5-fluoro-1h-pyrazoles starting from hexfluoropropane | |
| EP3166931A4 (en) | An improved process for the preparation of enzalutamide | |
| IL248267B (en) | A process for preparing converted cycloserines | |
| IL248566B (en) | A process for the preparation of 5-fluoro-1h-pyrazoles from hexafluoropropane | |
| IL255819A (en) | An improved process for the preparation of sofosbuvir and intermediates | |
| IL253077A0 (en) | Process and intermediates for the preparation of Fermpanel | |
| ZA201701973B (en) | Process for the preparation of halo-substituted trifluoroacetophenones | |
| IL247443B (en) | Process for the preparation of 5-fluorotryptophol | |
| IL237572A0 (en) | Process and intermediates for the preparation of dastinib | |
| PT3102565T (pt) | Processos para a preparação de intermediários de raltegravir | |
| IL248848A0 (en) | A process for preparing azd5363 and a novel intermediate for use in the process | |
| IL241974A0 (en) | Process for making erlotinib | |
| HUP1400518A2 (hu) | Eljárás tofacitinib elõállítására | |
| PL3230268T3 (pl) | Sposób wytwarzania tetrakonazolu | |
| EP3344249A4 (en) | Processes for the preparation of ivacaftor |